Anti-klk5

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Anti-KLK5 antibody produced in rabbit has been used in immunohistochemistry (1.0 μg/mL).

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies^® protocols and other useful information.

Biochem/physiol Actions

The gene KLK5 (kallikrein related peptidase 5) encodes a serine protease that is also referred to as KLK-L2 or human stratum corneum tryptic enzyme that is involved in the degradation of corneodesmosome proteins at the epidermal surface. This is a necessary step in desquamation. The corneodesmosome proteins comprising of corneodesmosin (CDSN), desmoglein 1 (DSG1), and desmocollin 1 (DSC1) mediate corneocyte cohesion. KLK5 expression is linked to more aggressive forms of epithelial ovarian carcinoma and it may serve as an independent prognostic marker of poor prognosis in ovarian cancer.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Features and Benefits

Prestige Antibodies^® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies^® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.Every Prestige Antibody is tested in the following ways: IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues. Protein array of 364 human recombinant protein fragments.

General description

The gene KLK5 (kallikrein related peptidase 5) encodes a serine protease that is a member of the kallikrein gene family. Its expression is abundant in skin, mammary gland and testis. The gene is localized to a gene cluster at human chromosome 19q13.2-q13.4. The encoded protein is synthesized as a preproenzyme containing an N-terminal signal peptide (prezymogen) followed by an activation peptide and the enzymatic domain. It is highly homologous to the enamel matrix serine proteinase 1 (EMSP1).

Immunogen

Kallikrein-5 precursor recombinant protein epitope signature tag (PrEST)

Legal Information

Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC

Linkage

Corresponding Antigen APREST72196.

Physical form

Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide